The most sensitive laboratory biomarkers in the prognosis of cases were ferritin and D-dimer, the levels of which were significantly higher among patients with COVID-19 than in pregnant women without the disease, which was not observed for CRP. The gene discussed is CRP; the disease is COVID-19.